phosphotyrosine has been researched along with tautomycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamaguchi, T; Osada, H; Sudo, T | 1 |
| Jensen, MR; Li, H; Okamoto, K; Prives, C; Taya, Y; Thorgeirsson, SS; Zhang, T | 1 |
2 other study(ies) available for phosphotyrosine and tautomycin
| Article | Year |
|---|---|
RK-682, a potent inhibitor of tyrosine phosphatase, arrested the mammalian cell cycle progression at G1phase.
Topics: Aniline Compounds; Antifungal Agents; Blotting, Western; cdc25 Phosphatases; Cell Cycle; Cell Cycle Proteins; Dual Specificity Phosphatase 3; Enzyme Inhibitors; Ethers, Cyclic; G1 Phase; Humans; Kinetics; Leukemia, B-Cell; Okadaic Acid; Organophosphorus Compounds; Phosphoprotein Phosphatases; Phosphoproteins; Phosphotyrosine; Protein Tyrosine Phosphatases; Pyrans; Spiro Compounds; Streptomyces; Tumor Cells, Cultured; Vanadates | 1995 |
Cyclin G recruits PP2A to dephosphorylate Mdm2.
Topics: Animals; Antifungal Agents; Catalysis; Chlorocebus aethiops; COS Cells; Cyclin G; Cyclin G1; Cyclins; Cyclosporine; Enzyme Inhibitors; Humans; Macromolecular Substances; Mice; Nuclear Proteins; Okadaic Acid; Phosphoprotein Phosphatases; Phosphorylation; Phosphotyrosine; Protein Binding; Protein Interaction Mapping; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Subunits; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Pyrans; Recombinant Fusion Proteins; Species Specificity; Spiro Compounds; Transfection; Tumor Suppressor Protein p53 | 2002 |